DXM Abuse Prevention Act of 2019
Latest action · Jan 30, 2019 Referred to the House Committee on Energy and Commerce.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedJan 30, 2019
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
DXM Abuse Prevention Act of 2019
This bill addresses the sale and distribution of dextromethorphan (DXM).
Specifically, the bill requires a retailer that sells certain drugs containing DXM to have a verification system that is intended to ensure that no one under 18 years of age purchases such drugs from the retailer.
The bill also establishes restrictions on (1) the sale of over-the-counter drugs containing DXM, and (2) the distribution of bulk DXM.
Cosponsors 3
Members who signed on, in the order they did. Signatures ran from Jan 30, 2019 to Feb 7, 2019; 1 is an original cosponsor, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-OH | Bill Johnson | Original | Jan 30, 2019 |
| D-NY | Yvette D. Clarke | Feb 6, 2019 | |
| D-WI | Ron Kind | Feb 7, 2019 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Jan 30, 2019 |
Actions 2
Everything that happened, newest first.
- Jan 30, 2019Introduced in House
- Jan 30, 2019Referred to the House Committee on Energy and Commerce.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 165, no. 19, January 30, 2019, page H1337.
Printed hearings 1
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| S. Hrg. 116-510 | MILITARY SPACE OPERATIONS, POLICY, AND PROGRAMS105 pages | Armed Services Committee | Mar 27, 2019 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend the Federal Food, Drug, and Cosmetic Act to prevent the abuse of dextromethorphan, and for other purposes.
- Short Title(s) as Introduced
- DXM Abuse Prevention Act of 2019
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Jan 30, 2019Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.